John J. Wright

3.1k citations

65 papers · 2.4k indexed · 1 hit paper · h-index 27

Impact in

Dermatology top 2%
- Cutaneous lymphoproliferative disorders research
Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- ATP Synthase and ATPases Research

Papers in ⓘ

Structural Biology 1
Organic Chemistry 20
- Synthesis of β-Lactam Compounds 5
- Synthesis and Catalytic Reactions 5

Co-authors: Seth M. Steinberg (4 shared papers)Richard Piekarz (4 shared papers)Susan E. Bates (4 shared papers)Judy Hirst (11 shared papers)William D. Figg (4 shared papers)Maxie M. Roessler (10 shared papers)Robin Frye (3 shared papers)Steven L. Allen (2 shared papers)
Journals: Journal of Medicinal Chemistry (9 papers)Clinical Cancer Research (4 papers)Journal of the American Chemical Society (4 papers)Nature Communications (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

John J. Wright

61 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma 2009 · 561 citations

Peers

Countries citing papers authored by John J. Wright

Since Specialization

Citations

This map shows the geographic impact of John J. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Wright more than expected).

Fields of papers citing papers by John J. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Wright. The network helps show where John J. Wright may publish in the future.

Co-authors

The 25 scholars most cited alongside John J. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John J. Wright Line = papers co-authored together John J. Wright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Journal of Clinical Oncology ·Richard Piekarz, Robin Frye, Maria L. Turner, John J. Wright, Steven L. Allen, Mark Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig B. Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler‐Stevenson, Stephen Lade, Antonio Tito Fojo, Susan E. Bates Hit paper breakdown →	2009	561
2	Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma Clinical Cancer Research ·Richard Piekarz, A. Robin Frye, John J. Wright, Seth M. Steinberg, David J. Liewehr, Douglas R. Rosing, Vandana Sachdev, Tito Fojo, Susan E. Bates	2006	188
3	Host–microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake British Journal Of Nutrition ·Camilla Pedersen, Edith Gallagher, Felicity Horton, Richard J. Ellis, Umer Zeeshan Ijaz, Huihai Wu, Etana Jaiyeola, Onyinye Diribe, Thibaut Duparc, Patrice D. Cani, Glenn R. Gibson, Paul Hinton, John J. Wright, Roberto M. La Ragione, M. Denise Robertson	2016	96
4	Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin Clinical Cancer Research ·David S. Schrump, Maria R. Fischette, Dao Nguyen, Ming Zhao, (unknown), Tricia Kunst, Ana Hancox, Julie A. Hong, G. Aaron Chen, Evgeny Kruchin, John J. Wright, Douglas R. Rosing, Alex Sparreboom, William D. Figg, Seth M. Steinberg	2008	92
5	Structure of inhibitor-bound mammalian complex I Nature Communications ·Hannah R. Bridges, Justin G. Fedor, James N. Blaza, Andrea Di Luca, Alexander Jussupow, Owen D. Jarman, John J. Wright, Ahmed-Noor A. Agip, Ana P. Gámiz‐Hernández, Maxie M. Roessler, Ville R. I. Kaila, Judy Hirst	2020	78
6	A phase II study of perifosine in androgen independent prostate cancer Cancer Biology & Therapy ·Edwin M. Posadas, James L. Gulley, Philip M. Arlen, A. Trout, Howard L. Parnes, John J. Wright, Min-Jung Lee, Eun Joo Chung, Jane B. Trepel, Alex Sparreboom, Clara Chen, Elizabeth C. Jones, Seth M. Steinberg, Andrew Daniels, William D. Figg, William L. Dahut	2005	74
7	Retuning the Catalytic Bias and Overpotential of a [NiFe]-Hydrogenase via a Single Amino Acid Exchange at the Electron Entry/Exit Site Journal of the American Chemical Society ·Hope Adamson, Martin Robinson, John J. Wright, Lindsey A. Flanagan, Julia Walton, Darrell Elton, David J. Gavaghan, Alan M. Bond, Maxie M. Roessler, Alison Parkin	2017	64
8	Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers Clinical Cancer Research ·Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer, Kambiz Ghafourian, James C. Reynolds, Deb Draper, Robin Frye, Sue Woo, David Venzon, John J. Wright, Monica C. Skarulis, William D. Figg, Tito Fojo, Susan E. Bates, Richard Piekarz	2013	57
9	Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Journal of Medicinal Chemistry ·S.Y. Sit, Richard Parker, Ioan Moţoc, Wenfei Han, N Balasubramanian, John D. Catt, Peter J. Brown, William E. Harte, Michael D. Thompson, John J. Wright	1990	55
10	Cryo-EM structures define ubiquinone-10 binding to mitochondrial complex I and conformational transitions accompanying Q-site occupancy Nature Communications ·Injae Chung, John J. Wright, Hannah R. Bridges, Bozhidar S. Ivanov, Olivier Biner, Caroline S. Pereira, Guilherme M. Arantes, Judy Hirst	2022	53
11	A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay Journal of Chromatography B ·Ming Zhao, Michelle A. Rudek, Ping He, Frank‐Thorsten Hafner, Martin Radtke, John J. Wright, B. Douglas Smith, Wells A. Messersmith, Manuel Hidalgo, Sharyn D. Baker	2006	48
12	Synthesis of 1-N-ethylsisomicin: a broad-spectrum semisynthetic aminoglycoside antibiotic Journal of the Chemical Society Chemical Communications ·John J. Wright	1976	45
13	Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors. Clinical Cancer Research ·Wells A. Messersmith, Sharyn D. Baker, Lance K. Lassiter, Rana Sullivan, Kimberly Dinh, Virna I Almuete, John J. Wright, Ross C. Donehower, Michael A. Carducci, Deborah K. Armstrong	2006	44
14	Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series Journal of Medicinal Chemistry ·Niranjan Balasubramanian, Denis R. St. Laurent, Marianne E. Federici, Nicholas A. Meanwell, John J. Wright, William A. Schumacher, Steven M. Seiler	1993	43
15	Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid Journal of Medicinal Chemistry ·Nicholas A. Meanwell, J. Romine, Michael Rosenfeld, Scott Martin, Ashok K. Trehan, John J. Wright, Mary F. Malley, Jack Z. Gougoutas, Catherine L. Brassard	1993	43
16	Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients Investigational New Drugs ·Maria Cristina Villarroel, Keith W. Pratz, Linping Xu, John J. Wright, B. Douglas Smith, Michelle A. Rudek	2011	41
17	Interaction of vicinal and nonvicinal amino-hydroxy group pairs in aminoglycoside-aminocyclitol antibiotics with transition metal cations. Selective N protection Journal of the American Chemical Society ·T. L. NAGABHUSHAN, Alan Cooper, William N. Turner, H. Tsai, Stuart W. McCombie, Alan K. Mallams, D. F. Rane, John J. Wright, Paul Reichert	1978	41
18	A high proportion of early response genes are constitutively activated in T cells by HTLV-I. PubMed ·Kathleen Kelly, Paula Davis, Hiroaki Mitsuya, Steven G. Irving, John J. Wright, Ralph Grassmann, Bernhard Fleckenstein, Yuji Wano, Warner C. Greene, Ulrich Siebenlist	1992	38
19	The importance of endogenous histamine relative to dietary histamine in the aetiology of scombrotoxicosis Food Additives & Contaminants ·P. Ijomah, Michael N. Clifford, Rheeda L. Walker, John J. Wright, R. Hardy, C. K. Murray	1991	36
20	Using Hyperfine Electron Paramagnetic Resonance Spectroscopy to Define the Proton-Coupled Electron Transfer Reaction at Fe–S Cluster N2 in Respiratory Complex I Journal of the American Chemical Society ·Nolwenn Le Breton, John J. Wright, Andrew J. Y. Jones, (unknown), Hannah R. Bridges, Judy Hirst, Maxie M. Roessler	2017	36

About John J. Wright

John J. Wright is a scholar working on Structural Biology, Organic Chemistry, Molecular Biology, Molecular Medicine and Biophysics, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Photosynthetic Processes and Mechanisms (7 papers), ATP Synthase and ATPases Research (6 papers), Metalloenzymes and iron-sulfur proteins (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Synthesis of β-Lactam Compounds (5 papers), Mitochondrial Function and Pathology (5 papers) and Synthesis and Catalytic Reactions (5 papers). The work is most often cited by research in Dermatology (232 citations), Molecular Biology (1.5k citations), Oncology (443 citations), Pathology and Forensic Medicine (260 citations) and Immunology (253 citations). John J. Wright has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Seth M. Steinberg, Richard Piekarz, Susan E. Bates, Judy Hirst, William D. Figg, Maxie M. Roessler, Robin Frye, Steven L. Allen, Jasmine Zain and Mark Kirschbaum. Their work appears in journals such as Journal of Medicinal Chemistry, Clinical Cancer Research, Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact